All analyzed patients (n = 178) | Good prognosis (n = 119) | Poor prognosis (n = 42) | p–value # | |
---|---|---|---|---|
Age | 69 (64 – 75) | 68 (65 – 74) | 69 (63 – 75) | 0.958 |
Sex Men / Women | 140 / 38 | 92 / 27 | 34 / 8 | 0.623 |
Outcome | ||||
Survival / Death / Unknown | 73 / 81 / 24 | |||
GAP stage I / II / III | 93 / 64 / 21 | 72 / 41 / 6 | 15 / 14 / 13 | < 0.001* |
BMI | 23.5 (21.5 – 25.9) | 23.5 (22.2 – 25.9) | 22.7 (20.2 – 25.7) | 0.102 |
Smoking | ||||
Current or former / Never | 146 / 32 | 98 / 21 | 34 / 8 | 0.839 |
Pack-years | 35 (10 – 50) | 35 (10 – 50) | 35 (7 – 49) | 0.692 |
Comorbidities | ||||
Acute exacerbation of ILDa | 4 (2.3) | 1 (1.1) | 3 (7.3) | 0.024* |
Cancer other than lung cancer | 17 (10.6) | 12 (12.8) | 1 (2.4) | 0.115 |
Hypertension | 63 (54.8) | 42 (44.7) | 14 (34.1) | 0.819 |
Hyperlipidemia | 40 (29.0) | 18 (19.1) | 13 (31.7) | 0.025* |
Diabetes | 40 (29.0) | 29 (30.9) | 7 (17.1) | 0.303 |
Heart diseases | 27 (17.9) | 12 (12.8) | 8 (19.5) | 0.130 |
Arrhythmia | 7 (4.1) | 3 (3.2) | 4 (9.8) | 0.056 |
Pulmonary hypertension | 7 (4.1) | 5 (5.3) | 1 (2.4) | 0.592 |
Cerebrovascular diseases | 14 (8.5) | 8 (8.5) | 5 (12.2) | 0.289 |
Gastroesophageal reflux | 14 (8.5) | 11 (11.7) | 3 (7.3) | 0.678 |
Chronic renal diseases | 17 (10.6) | 10 (10.6) | 7 (17.1) | 0.090 |
Bronchial asthma | 10 (6.0) | 8 (8.5) | 2 (4.9) | 0.651 |
Indices of the PFT | ||||
VC (L) | 2.63 (2.18 – 3.39) | 2.95 (2.39 – 3.56) | 2.23 (1.76 – 2.59) | < 0.001* |
%VC | 87.8 (71.0 – 102.0) | 96.5 (77.4 – 109.0) | 70.3 (59.3 – 80.2) | < 0.001* |
FVC (L) | 2.60 (2.12 – 3.35) | 2.89 (2.29 – 3.49) | 2.12 (1.77 – 2.60) | < 0.001* |
%FVC | 86.1 (69.7 – 101.7) | 95.7 (78.1 – 107.1) | 68.4 (59.7 – 80.6) | < 0.001* |
FEV1 (L) | 2.15 (1.82 – 2.61) | 2.27 (1.91 – 2.73) | 1.91 (1.63 – 2.26) | < 0.001* |
FEV1/FVC (%) | 82.6 (77.4 – 87.6) | 81.2 (76.7 – 84.6) | 88.8 (83.5 – 93.4) | < 0.001* |
DLCO (ml/min/mmHg)b | 11.37 (9.36 – 14.91) | 12.27 (10.01 – 15.61) | 9.94 (8.54 – 11.99) | < 0.001* |
%DLCOb | 55.2 (44.5 – 66.3) | 58.6 (48.5 – 71.8) | 45.8 (35.9 – 57.0) | < 0.001* |
Indices of the oscillometry | ||||
R5 (cmH2O/L/s) | ||||
Whole breath | 2.70 (2.28 – 3.24) | 2.73 (2.30 – 3.31) | 2.78 (2.28 – 3.24) | 0.817 |
Ex | 2.84 (2.39 – 3.70) | 2.86 (2.44 – 3.69) | 2.83 (2.39 – 3.73) | 0.703 |
In | 2.46 (1.99 – 3.01) | 2.47 (1.95 – 3.02) | 2.42 (2.11 – 2.98) | 0.774 |
ΔR5 | 0.37 (0.15 – 0.75) | 0.38 (0.17 – 0.88) | 0.39 (0.04 – 0.74) | 0.872 |
R20 (cmH2O/L/s) | ||||
Whole breath | 2.07 (1.76 – 2.48) | 2.15 (1.79 – 2.51) | 1.94 (1.75 – 2.63) | 0.424 |
Ex | 2.13 (1.80 – 2.67) | 2.22 (1.81 – 2.70) | 2.04 (1.78 – 2.80) | 0.330 |
In | 1.99 (1.68 – 2.42) | 1.99 (1.70 – 2.44) | 1.88 (1.66 – 2.42) | 0.494 |
ΔR20 | 0.12 (–0.05 – 0.40) | 0.10 (–0.04 – 0.48) | 0.16 (–0.11 – 0.39) | 0.526 |
R5–R20 (cmH2O/L/s) | ||||
Whole breath | 0.62 (0.43 – 0.83) | 0.60 (0.39 – 0.82) | 0.62 (0.46 – 0.84) | 0.474 |
Ex | 0.76 (0.48 – 1.00) | 0.75 (0.47 – 0.99) | 0.81 (0.60 – 1.00) | 0.586 |
In | 0.47 (0.32 – 0.69) | 0.47 (0.30 – 0.68) | 0.49 (0.38 – 0.70) | 0.376 |
ΔR5–R20 | 0.25 (0.08 – 0.43) | 0.25 (0.10 – 0.45) | 0.28 (0.11 – 0.42) | 0.817 |
X5 (cmH2O/L/s) | ||||
Whole breath | –0.87 (–1.16 to –0.48) | –0.75 (–1.04 to –0.40) | –1.14 (–1.66 to –0.97) | < 0.001* |
Ex | –0.90 (–1.24 to –0.44) | –0.78 (–1.14 to –0.33) | –1.15 (–1.47 to –0.84) | < 0.001* |
In | –0.82 (–1.17 to –0.50) | –0.73 (–0.98 to –0.37) | –1.18 (–1.87 to –0.83) | < 0.001* |
ΔX5 | 0.04 (–0.12 – 0.20) | 0.03 (–0.14 – 0.19) | 0.07 (–0.05 – 0.25) | 0.121 |
Fres (Hz) | ||||
Whole breath | 10.38 (7.88 – 12.34) | 9.63 (7.46 – 11.17) | 11.87 (10.38 – 14.30) | < 0.001* |
Ex | 10.16 (7.80 – 12.48) | 9.61 (7.16 – 11.72) | 11.82 (10.08 – 13.80) | < 0.001* |
In | 10.22 (8.20 – 12.09) | 9.50 (7.57 – 11.32) | 11.80 (10.22 – 14.83) | < 0.001* |
ΔFres | –0.14 (–1.11 – 0.76) | –0.18 (–1.04 – 0.94) | –0.22 (–1.22 – 0.22) | 0.281 |
ALX (cmH2O/L/s) | ||||
Whole breath | 3.71 (1.74 – 5.85) | 3.06 (1.34 – 4.80) | 5.62 (4.13 – 9.30) | < 0.001* |
Ex | 3.72 (1.57 – 6.01) | 2.86 (1.07 – 5.37) | 5.66 (3.50 – 8.42) | < 0.001* |
In | 3.43 (1.83 – 5.68) | 2.95 (1.28 – 4.55) | 5.84 (3.44 – 11.17) | < 0.001* |
ΔALX | –0.24 (–0.97 – 0.62) | –0.13 (–0.72 – 0.67) | –0.62 (–1.53 – 0.38) | 0.013* |